Company history:
Dedicated to the application of biocatalysis ChiralVision was founded in 2006, privately funded with headquarters now in the Delft area situated between the major towns of Rotterdam and Den Hague, The Netherlands
Some "historic" highlights:
2006 - Founding of ChiralVision in Leiden, the Netherlands
2006 - Introduction of first Immozymes and chiral products
2006 - 1st patented custom API process
2007 - Collaboration with Genencor International
2008 - Products available via Sigma-Aldrich
2008 - 1st Immozyme in API production process
2009 - Over 100 immobilized enzyme products
2010 - Over 60 unique chiral compounds in portfolio
2010 - Food & Nutrition Delta funding for "healthy fats"
2012 - EU funding for clean water research (Endetech)
2013 - EU project for phosphate recycling (Phosfarm)
2015 - Collaboration with Nordic Chemquest (now SpinChem) for SpinChem reactor development
2016 - Eurostars funding for biocide replacement (Bio-Attract).
2016 - ERA-IB (Industrial Biotechnology) project “No P” for enzymatic sugar coupling reactions.
2019 - Move into new and larger facilities in Den Hoorn, the Netherlands
2019 - MACBETH project: Membranes And Catalysts Beyond Economic and Technological Hurdles. Budget: 20,7 M€